INVO Bioscience, Inc. (NasdaqCM: INVO) Loss Submission Form

Kuznicki Law is investigating the proposed merger of INVO Bioscience, Inc. (the “Company”) (NasdaqCM: INVO) with NAYA Biosciences Inc. Under the terms of the proposed transaction, (subject to the Interim PIPE, post-transaction and prior to the private offering), INVO shareholders will own approximately 12% of the combined company. Kuznicki Law is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.